A Phase II, Multi-center, Open-label Study Evaluating GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2016
At a glance
- Drugs Paclitaxel trevatide (Primary) ; Trastuzumab
- Indications Advanced breast cancer; Brain metastases
- Focus Therapeutic Use
- Acronyms GRABM-B
- Sponsors AngioChem
- 03 Jun 2016 Status changed from active, no longer recruiting to completed.
- 09 Nov 2015 Results of a biomarker sub-study (n=10) presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2015.
- 02 Jun 2015 Results of biomarker substudy (n=10) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History